DOI:
10.1055/s-00000034
Klinische Pädiatrie
LinksClose Window
References
Millot F, Baruchel A, Guilhot J et al.
Imatinib is efficient but has a negative impact on growth in children with previously untreated chronic myelogenous leukaemia (CML) in early chronic phase (CP): results of the French National Phase IV Trial.
Blood 2009;
110: 863
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.